4.3 Article

Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line

期刊

出版社

SPRINGER
DOI: 10.1007/s11626-015-9885-z

关键词

Mesothelioma; Asbestos; Mouse cell lines; Cell models; Immortalized; SV40

向作者/读者索取更多资源

Mesothelial cells are susceptible to asbestos fiber-induced cytotoxicity and on longer time scales to transformation; the resulting mesothelioma is a highly aggressive neoplasm that is considered as incurable at the present time Zucali et al. (Cancer Treatment Reviews 37:543-558, 2011). Only few murine cell culture models of immortalized mesothelial cells and mesothelioma cell lines exist to date. We generated SV40-immortalized cell lines derived from wild-type (WT) and neurofibromatosis 2 (merlin) heterozygote (Nf2+/-) mice, both on a commonly used genetic background, C57Bl/6J. All immortalized mesothelial clones consistently grow in DMEM supplemented with fetal bovine serum. Cells can be passaged for more than 40 times without any signs of morphological changes or a decrease in proliferation rate. The tumor suppressor gene NF2 is one of the most frequently mutated genes in human mesothelioma, but its detailed function is still unknown. Thus, these genotypically distinct cell lines likely relevant for malignant mesothelioma formation are expected to serve as useful in vitro models, in particular to compare with in vivo studies in mice of the same genotype. Furthermore, we generated a novel murine mesothelioma cell line RN5 originating from an Nf2+/- mouse subjected to repeated crocidolite exposure. RN5 cells are highly tumorigenic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Forchlorfenuron and Novel Analogs Cause Cytotoxic Effects in Untreated and Cisplatin-Resistant Malignant Mesothelioma-Derived Cells

Thomas Henzi, Kim-Long Diep, Anne Oberson, Valerie Salicio, Christian G. Bochet, Beat Schwaller

Summary: Malignant mesothelioma (MM) is an aggressive cancer derived from mesothelial cells, often caused by asbestos exposure. The current treatment options are limited in effectiveness, hence the search for novel therapies. Recent research has identified septins as a potential target for treatment. Some FCF analogs have been found to inhibit the growth of MM cells in vitro, but at concentrations too high for clinical applications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations

Michele Carbone, Harvey Pass, Guntulu Ak, H. Richard Alexander, Paul Baas, Francine Baumann, Andrew M. Blakely, Raphael Bueno, Aleksandra Bzura, Giuseppe Cardillo, Jane E. Churpek, Irma Dianzani, Assunta De Rienzo, Mitsuru Emi, Salih Emri, Emanuela Felley-Bosco, Dean A. Fennell, Raja M. Flores, Federica Grosso, Nicholas K. Hayward, Mary Hesdorffer, Chuong D. Hoang, Peter A. Johansson, Hedy L. Kindler, Muaiad Kittaneh, Thomas Krausz, Aaron Mansfield, Muzaffer Metintas, Michael Minaai, Luciano Mutti, Maartje Nielsen, Kenneth O'Byrne, Isabelle Opitz, Sandra Pastorino, Francesca Pentimalli, Marc de Perrot, Antonia Pritchard, Robert Taylor Ripley, Bruce Robinson, Valerie Rusch, Emanuela Taioli, Yasutaka Takinishi, Mika Tanji, Anne S. Tsao, A. Murat Tuncer, Sebastian Walpole, Andrea Wolf, Haining Yang, Yoshie Yoshikawa, Alicia Zolondick, David S. Schrump, Raffit Hassan

Summary: The most common malignancies that develop in carriers of BAP1 germline mutations include mesothelioma, melanoma, renal cell carcinoma, and other tumor types. The features of malignancies can vary among individuals, and a multidisciplinary approach is required for diagnosis and treatment. Detecting BAP1 germline mutations has significant medical, social, and economic impact.

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Multidisciplinary Sciences

Hand2 delineates mesothelium progenitors and is reactivated in mesothelioma

Karin D. Prummel, Helena L. Crowell, Susan Nieuwenhuize, Eline C. Brombacher, Stephan Daetwyler, Charlotte Soneson, Jelena Kresoja-Rakic, Manuel Ronner, Agnese Kocere, Alexander Ernst, Zahra Labbaf, David E. Clouthier, Anthony B. Firulli, Hector Sanchez-Iranzo, Sundar R. Naganathan, Rebecca O'Rourke, Erez Raz, Nadia Mercader, Alexa Burger, Emanuela Felley-Bosco, Jan Huisken, Mark D. Robinson, Christian Mosimann

Summary: This study uncovers the early origins of mesothelium progenitor cells in zebrafish, linking the function of the Hand2 gene to mesothelium formation and the re-activation of mesothelioma tumors.

NATURE COMMUNICATIONS (2022)

Editorial Material Oncology

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies

Giulia Pasello, Jordi Remon, Emanuela Felley-Bosco

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Genomic landscape of pleural and peritoneal mesothelioma tumours

Stefanie Hiltbrunner, Zoe Fleischmann, Ethan S. Sokol, Martin Zoche, Emanuela Felley-Bosco, Alessandra Curioni-Fontecedro

Summary: This study analyzed the molecular characteristics of a large cohort of pleural and peritoneal mesothelioma samples, identifying some alterations with potential therapeutic targets and suggesting that molecular profiling can lead to new treatment options for patients with mesothelioma.

BRITISH JOURNAL OF CANCER (2022)

Article Biochemistry & Molecular Biology

The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition

Emanuela Felley-Bosco, Weihong Qi, Didier Jean, Clement Meiller, Hubert Rehrauer

Summary: This study reveals the association between RNA editing and the epithelial-mesenchymal transition (EMT) phenotype in pleural mesothelioma (PM). Analysis of RNA editing expression changes in PM samples showed increased editing in introns and decreased editing in 3' UTR in samples with EMT phenotype.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma

Licun Wu, Kosuke Yoshihara, Hana Yun, Saraf Karim, Nastaran Shokri, Fatemeh Zaeimi, H. S. Jeffrey Man, Amin Zia, Emanuela Felley-Bosco, Marc de Perrot

Summary: Malignant mesothelioma (MESO) has different subtypes and epithelial-mesenchymal transition (EMT) phenotypes. A panel of MESO EMT genes were found to be correlated with hypermethylation of epigenetic genes and loss of CDKN2A/B expression. The MESO EMT genes were associated with activation of TGF-beta, hedgehog, and IL-2-STAT5 signaling, and suppression of IFN-alpha and IFN-gamma response. Immune checkpoints were upregulated, while certain immune receptors were downregulated with the expression of MESO EMT genes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Licun Wu, Mikihiro Kohno, Junichi Murakami, Amin Zia, Jonathan Allen, Hana Yun, Meilin Chan, Cristina Baciu, Mingyao Liu, Veronique Serre-Beinier, Michele De Palma, Emanuela Felley-Bosco, Jonathan Yeung, Trevor J. Pugh, Marc de Perrot

Summary: Defining the origin of tumor-associated macrophages (TAM) is crucial for developing targeted therapies for mesothelioma. Two distinct macrophage populations, small peritoneal/pleural macrophages (SPM) and large peritoneal/pleural macrophages (LPM), were identified in mice. SPM, which mainly consisted of M2-like TAM, rapidly increased in the tumor microenvironment and contributed to tumor development. On the other hand, LPM activated the IFN-gamma response and played a crucial role in the immune response, as confirmed by their depletion leading to loss of antitumoral memory immunity. The gene signature of SPM was observed in the pleural effusion and tumor of untreated mesothelioma patients, suggesting potential therapeutic targets.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Oncology

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing

Alexander Laure, Angelica Rigutto, Michaela B. Kirschner, Lennart Opitz, Linda Grob, Isabelle Opitz, Emanuela Felley-Bosco, Stefanie Hiltbrunner, Alessandra Curioni-Fontecedro

Summary: Patient-derived cell lines show closer resemblance to MPM tumors in terms of genome and transcriptome compared to commercial cell lines. This finding has significant implications for using cell line models to study predictive biomarkers and interpret preclinical results that cannot be translated in clinical practice.

CANCERS (2023)

Article Engineering, Biomedical

Isolation of tumour-reactive lymphocytes from peripheral blood via microfluidic immunomagnetic cell sorting

Zongjie Wang, Sharif Ahmed, Mahmoud Labib, Hansen Wang, Licun Wu, Fatemeh Bavaghar-Zaeimi, Nastaran Shokri, Soraly Blanco, Saraf Karim, Kasia Czarnecka-Kujawa, Edward H. Sargent, A. J. Robert McGray, Marc de Perrot, Shana O. Kelley

Summary: Potent circulating tumour-reactive lymphocytes (cTRLs) can be isolated from peripheral blood at high yield and purity via microfluidic immunomagnetic cell sorting, allowing for comprehensive downstream analyses of these rare cells. This method provides a solution to the clinical challenge of obtaining large and fresh tumour fractions for the use of tumour-infiltrating lymphocytes in solid tumour treatment.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Cardiac & Cardiovascular Systems

Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Justin C. Y. Chan, H. S. Jeffrey Man, Usman M. Asghar, Karen Mcrae, Yidan Zhao, Laura L. Donahoe, Licun Wu, John Granton, Marc de Perrot

Summary: This study aimed to investigate the impact of sex on patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy. The results showed that female patients had a greater need for targeted PH medical therapy postoperatively, emphasizing the importance of early reassessment and long-term follow-up.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Review Biochemistry & Molecular Biology

Omics Overview of the SPARC Gene in Mesothelioma

Licun Wu, Marc de Perrot

Summary: The SPARC gene is involved in extracellular matrix synthesis, cell shaping, tumor cell migration, invasion, metastasis, and the epithelial-mesenchymal transition process. It is associated with poor survival in MESO patients and correlates with an immunosuppressive tumor microenvironment. The gene may be targeted by microRNAs and is implicated in tumor angiogenesis.

BIOMOLECULES (2023)

暂无数据